Ligand Adds New Expertise, Revenue Potential With Pfenex Buyout

 
• By Joseph Haas

Deal Snapshot: In acquiring its fellow San Diego firm for an estimated deal value of up to $516m, Ligand picks up protein-expression technology, revenue-driving partnerships and the potential for more.

isolation of home remodelling
Ligand would add on protein-expression technology if Pfenex buyout goes through

More from Deals

More from Business